Pfizer's Strategic Move: $43 Billion Seagen Acquisition Set to Close
Pfizer (PFE) is on the brink of concluding its monumental $43 billion acquisition of cancer drugmaker Seagen Inc. (SGEN), a deal that is set to significantly bolster its oncology portfolio. This acquisition,...